"Peptides, Cyclic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides whose amino and carboxy ends are linked together with a peptide bond forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS. Some of them are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL).
| Descriptor ID |
D010456
|
| MeSH Number(s) |
D04.345.566 D12.644.641
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptides, Cyclic".
Below are MeSH descriptors whose meaning is more specific than "Peptides, Cyclic".
This graph shows the total number of publications written about "Peptides, Cyclic" by people in this website by year, and whether "Peptides, Cyclic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 14 | 8 | 22 |
| 2018 | 13 | 2 | 15 |
| 2019 | 5 | 3 | 8 |
| 2020 | 2 | 4 | 6 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Peptides, Cyclic" by people in Profiles.
-
Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy. Ann Oncol. 2021 10; 32(10):1295-1297.
-
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals. J Autoimmun. 2021 08; 122:102682.
-
A cyclic peptide inhibitor of the SARS-CoV-2 main protease. Eur J Med Chem. 2021 Oct 05; 221:113530.
-
[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2]. Rev Esp Quimioter. 2021 Oct; 34(5):402-407.
-
Plitidepsin: a Repurposed Drug for the Treatment of COVID-19. Antimicrob Agents Chemother. 2021 03 18; 65(4).
-
Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury. Respir Physiol Neurobiol. 2021 06; 288:103645.
-
SARS-CoV-2 dependence on host pathways. Science. 2021 02 26; 371(6532):884-885.
-
Cyclic 68Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2. J Nucl Med. 2021 11; 62(11):1631-1637.
-
New Hopes for Drugs against COVID-19 Come from the Sea. Mar Drugs. 2021 Feb 11; 19(2).
-
Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors. Molecules. 2021 Feb 10; 26(4).